Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure

Heart

Volumn 82, Issue 3, 1999, Pages 352-356

  Murdoch, D R ^a   Rooney, E ^c   Dargie, H J ^a   Shapiro, D ^b   Morton, J J ^c   McMurray, J J V ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^c NONE

Author keywords

Cachexia; Cytokines; Heart failure; Leptin

Indexed keywords

LEPTIN; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BODY FAT; CACHEXIA; CASE CONTROL STUDY; CHRONIC DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HEART CATHETERIZATION; HEART FAILURE; HEART VALVE REGURGITATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY;

EID: 0032846516     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.82.3.352     Document Type: Article

References (33)

1. 1 Zhang YY, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homolog. Nature 1994;372:425-32.
2. 2 Considine RV, Sinha MK, Heiman MI., et al. Serum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-5.
3. 3 Banks WA, Kastin AJ, Huang WT, et al. Leptin enters the brain by a saturable system independent of insulin. Peptides 1996;17:305-11.
4. 4 Maffei M, Stoffel M, Barone M, et al. Absence of mutations in the human OB gene in obese/diabetic subjects. Diabetes 1996;45:679-82.
5. 5 Considine RV, Considine EL, Williams CJ, et al. Evidence against either a premature stop codon or the absence of obese gene messenger-RNA in human obesity. J Clin Invest 1995;95:2986-8.
6. 6 Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent-measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995;1:1155-61.
7. 7 McMurray JJV, Abdullah I, Dargie HJ, et al. Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. Br Heart J 1991;66:356-8.
8. 8 Levine B, Kalman J, Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236-41.
9. 9 Zhao SP, Zeng LH. Elevated plasma levels of tumor necrosis factor in chronic heart failure with cachexia. Int J Cardiol 1997;58:257-61.
10. 10 Sarraf P, Frederich RC, Turner EM, et al. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 1997;185:171-5.
11. 11 Grunfeld C, Zhao C, Kuller J, et al. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters A role for leptin in the anorexia of infection. J Clin Invest. 1996;97:2152-7.
12. 12 Zumbach MS, Boehme MWJ, Wahl P, et al. Tumor necrosis factor increases serum leptin levels in humans. J ClinEndocrinol Metab 1997;82:4080-2.
13. 13 Simons JPFHA, Schols AMWJ, Campfield LA, et al. Plasma concentration of total leptin and human lung-cancer-associated cachexia. Clin Sci 1997;93:273-7.
14. 14 Durnin JV, Rahaman MM. The assessment of the amount of fat in the human body from measurements of skinfold thickness. Br J Nutr 1967;21:681-9.
15. 15 Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974;32:77-97.
16. 16 Goldstein DS, Feuerstein G, Izzo JI., et al. Validity and reliability of liquid-chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci 1981;28:467-75.
17. 17 Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res 1980;47:1-9.
18. 18 Anand IS, Ferrari R, Kalra GS, et al. Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation 1989;80:299-305.
19. 19 Swan JW, Walton C, Godsland IF, et al. Insulin resistance in chronic heart failure. Eur Heart J 1994;15:1528-32.
20. 20 Anker SD, Chua TP, Ponikowski P, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997;96:526-34.
21. 21 Cumin F, Baum HP, Levens N. Leptin is cleared from the circulation primarily by the kidney. Im J Obes Relat Metab Disord 1996;20:1120-6.
22. 22 Esler M, Vaz M, Collier G, et al. Leptin in human plasma is derived in part from the brain, and cleared by the kidneys. Lancet 1998;351:879.
23. 23 Iida M, Murakami T, Yamada M, et al. Hyperleptinemia in chronic renal failure. Horm Metab Res 1996;28:724-7.
24. 24 Ansari A. Syndromes of cardiac cachexia and the cachectic heart: current perspective. Prog Cardiovasc Dis 1987;30:15-60.
25. 25 Morrison WL, Edwards RHT. Cardiac cachexia. RMJ 1991;302:301-2.
26. 26 Riley M, Elborn JS, McKane WR, et al. Resting energy expenditure in chronic cardiac failure. Clin Sci 1991;80: 633-9.
27. 27 Poehlman ET, Scheffers J, Gottlieb SS, et al. Increased resting metabolic rate in patients with congestive heart failure. Ann Intern Med 1994;121:860-2.
28. 28 Trayhurn P, Duncan JS, Rayner DV, et al. Rapid inhibition of ob gene expression and circulating leptin levels in lean mice by the beta 3-adrenoceptor agonists BRL 351 35A and ZD2079. Biochem Biophys Res Commun 1996;228:605-10.
29. 29 Gettys TW, Harkness PJ, Watson PM. The beta 3-adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rat adipocytes. Endocrinology 1996; 137:4054-7.
30. 30 Kosaki A, Yamada K, Kuzuya H. Reduced expression of the leptin gene (ob) by catecholamine through a G(s) protein-coupled pathway in 3T3-L1 adipocytes. Diabetes 1996,45: 1744-9.
31. 31 Trayhurn P, Duncan JS, Rayner DV. Acute cold-induced suppression of ob (obese) gene expression in white adipose tissue of mice: mediation by the sympathetic system. Biochem J 1995;311:729-33.
32. 32 Donahoo WT, Jensen DR, Yost TJ, et al. Isoproterenol and somatostatin decrease plasma leptin in humans: a novel mechanism regulating leptin secretion. J Clin Endocrinol Metab 1997;82:4139-43.
33. 33 Pelleymounter MA, Cullen MJ, Baker MB, et al. Effects of the obese gene-product on body-weight regulation in ob/ob mice. Science 1995;269:540-3.